MindBio Therapeutics Corp. has completed manufacturing of its next-generation Edge AI Intoxication Detection Kiosk, a hardware device designed to support the company's proprietary Voice AI technology for identifying potential drug or alcohol impairment through vocal analysis. The announcement, disseminated on behalf of MindBio Therapeutics Corp., signals progress in the company's effort to commercialize a rapid, non-invasive screening tool for safety-sensitive industries.
The new kiosk builds on a prototype developed in June and represents a more advanced iteration of the hardware. MindBio is continuing software integration, system testing, and validation of its predictive models against conventional breath alcohol and oral fluid testing methods. A potential initial commercial pilot is targeted for later this year, which would allow the company to evaluate the technology's performance in a real-world environment against existing testing methods.
The development matters because conventional drug and alcohol screening can be time-consuming, invasive, and costly for employers. MindBio is positioning its kiosk as a rapid alternative that could enable more frequent, large-scale workplace screening while potentially reducing testing costs, administration time, and operational disruptions. The company is targeting safety-sensitive sectors including mining, aviation, construction, heavy transport, and law enforcement, where impairment detection is critical to safety and compliance.
MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), a biotechnology company developing artificial intelligence-driven voice analytics for drug and alcohol intoxication detection, reports that its AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge-AI kiosks that integrate bespoke hardware and software for detection in a range of enterprise environments. For investors, the completion of manufacturing moves the company closer to a commercial pilot, a key milestone that could validate both the technology and its market potential.
To view the full press release, visit https://ibn.fm/UN9LN. The latest news and updates relating to MBQIF are available in the company's newsroom at https://ibn.fm/MBQIF. The announcement was distributed through TechMediaWire, a specialized communications platform focused on pioneering public and private companies driving the future of technology. TechMediaWire is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire and other services. Full terms of use and disclaimers are available at https://www.TechMediaWire.com/Disclaimer.
